BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fycompa perampanel regulatory update

Eisai said it will "temporarily" suspend commercial distribution of epilepsy drug Fycompa perampanel in Germany. The move comes after Germany's Federal Joint Committee (G-BA) issued a final benefit assessment in March that found Fycompa...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >